Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/11792750

J. Natl. Cancer Inst. 2002 Jan 16 94 2 116-28

Download in:

View as

Triples

General Info

PMID
11792750